250 related articles for article (PubMed ID: 7988433)
1. Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2.
Hanisch UK; Rowe W; Sharma S; Meaney MJ; Quirion R
Endocrinology; 1994 Dec; 135(6):2465-72. PubMed ID: 7988433
[TBL] [Abstract][Full Text] [Related]
2. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
3. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
[TBL] [Abstract][Full Text] [Related]
4. Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by intermittent footshock or interleukin.
Rivest S; Rivier C
Endocrinology; 1991 Oct; 129(4):2049-57. PubMed ID: 1655391
[TBL] [Abstract][Full Text] [Related]
5. Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague-Dawley rats.
Fediuc S; Campbell JE; Riddell MC
J Appl Physiol (1985); 2006 Jun; 100(6):1867-75. PubMed ID: 16439512
[TBL] [Abstract][Full Text] [Related]
6. Phasic hyperactivity of the HPA axis resulting from chronic central IL-2 administration.
Hanisch UK; Rowe W; van Rossum D; Meaney MJ; Quirion R
Neuroreport; 1996 Nov; 7(18):2883-8. PubMed ID: 9116202
[TBL] [Abstract][Full Text] [Related]
7. Effect of subdiaphragmatic vagotomy on the noradrenergic and HPA axis activation induced by intraperitoneal interleukin-1 administration in rats.
Wieczorek M; Dunn AJ
Brain Res; 2006 Jul; 1101(1):73-84. PubMed ID: 16784727
[TBL] [Abstract][Full Text] [Related]
8. Acute stress-induced facilitation of the hypothalamic-pituitary-adrenal axis: evidence for the roles of stressor duration and serotonin.
Cassano WJ; D'mello AP
Neuroendocrinology; 2001 Sep; 74(3):167-77. PubMed ID: 11528218
[TBL] [Abstract][Full Text] [Related]
9. Role of the dorsomedial hypothalamus in glucocorticoid-mediated feedback inhibition of the hypothalamic-pituitary-adrenal axis.
Stamper CE; Hennessey PA; Hale MW; Lukkes JL; Donner NC; Lowe KR; Paul ED; Spencer RL; Renner KJ; Orchinik M; Lowry CA
Stress; 2015 Jan; 18(1):76-87. PubMed ID: 25556980
[TBL] [Abstract][Full Text] [Related]
10. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
Ochedalski T; Subburaju S; Wynn PC; Aguilera G
J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
[TBL] [Abstract][Full Text] [Related]
11. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
Naert G; Ixart G; Tapia-Arancibia L; Givalois L
Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
[TBL] [Abstract][Full Text] [Related]
12. Brain nitric oxide synthases in the interleukin-1β-induced activation of hypothalamic-pituitary-adrenal axis.
Gądek-Michalska A; Tadeusz J; Rachwalska P; Spyrka J; Bugajski J
Pharmacol Rep; 2012; 64(6):1455-65. PubMed ID: 23406756
[TBL] [Abstract][Full Text] [Related]
13. Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies.
Sweep CG; van der Meer MJ; Hermus AR; Smals AG; van der Meer JW; Pesman GJ; Willemsen SJ; Benraad TJ; Kloppenborg PW
Endocrinology; 1992 Mar; 130(3):1153-64. PubMed ID: 1311230
[TBL] [Abstract][Full Text] [Related]
14. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.
Heiman ML; Ahima RS; Craft LS; Schoner B; Stephens TW; Flier JS
Endocrinology; 1997 Sep; 138(9):3859-63. PubMed ID: 9275075
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.
Newsom RJ; Osterlund C; Masini CV; Day HE; Spencer RL; Campeau S
Neuroscience; 2012 Mar; 204():64-73. PubMed ID: 22138156
[TBL] [Abstract][Full Text] [Related]
16. Relationships among the behavioral, noradrenergic, and pituitary-adrenal responses to interleukin-1 and the effects of indomethacin.
Wieczorek M; Dunn AJ
Brain Behav Immun; 2006 Sep; 20(5):477-87. PubMed ID: 16330180
[TBL] [Abstract][Full Text] [Related]
17. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.
Gadek-Michalska A; Bugajski AJ; Bugajski J
J Physiol Pharmacol; 2008 Sep; 59(3):563-75. PubMed ID: 18953098
[TBL] [Abstract][Full Text] [Related]
19. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity.
Chan O; Inouye K; Vranic M; Matthews SG
Endocrinology; 2002 May; 143(5):1761-8. PubMed ID: 11956158
[TBL] [Abstract][Full Text] [Related]
20. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
